Astrazeneca Pharma India has informed that a meeting of the Board of Directors of the company will be held on Monday, August 10, 2020 to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2020 and consider declaration of an Interim Dividend to the equity shareholders of the Company for the financial year 2020-21. The company has informed that the ‘Trading Window’ remains closed for all Designated Persons, from June 16, 2020 to August 12, 2020 in terms of the company Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.
The above information is a part of company’s filings submitted to BSE.
